Evaluate and optimize a virtual care model for PrEP delivery

This pilot study aims to develop, test, and refine a novel online model of PrEP delivery in collaboration with MYDAWA, an online pharmaceutical retail platform in Kenya. The specific PrEP products to be delivered through this platform include TDF/FTC daily oral PrEP and Dapivirine Ring, with consideration to support the delivery of a monthly oral formulation after 2024 if Islatravir proves safe and efficacious in phase 3 trial. The pilot is being conducted in the greater Nairobi area in collaboration with the Partners in Health and Research Development Clinic (Site PI: Dr. Kenneth Ngure), Jhpiego Kenya (Co-Investigator: Daniel Were), and MYDAWA (Co-Investigator: Tony Wood). Funding is provided through the Bill & Melinda Gates Foundation through 2023.